Cold Water Immersion in the Recovery of Markers of Muscle Damage of 10km Street Runners

Cold Water Immersion in the Recovery of Clinical, Biochemical, Functional and Neuromuscular Markers of Muscle Damage of 10km Street Runners: Clinical, Randomized and Blinded Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03094689

Enrollment

Registered

2017-03-29

Start date

2017-01-31

Completion date

2017-04-30

Last updated

2017-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior

Keywords

Physical activity, Muscle pain, Cryotherapy

Brief summary

Objective: To analyze the effect of cold water immersion (CWI) on the recovery of clinical, biochemical, functional and neuromuscular markers of muscle damage in 10 km street runners. Materials and Methods: This is a randomized, blinded trial in which 30 subjects, 10 km street runners, were randomly divided into three groups: control (gC), immersion (gI) and CWI (gCWI). The runners will be evaluated for clinical (subjective perception of exertion), biochemical (serum CK), functional (unipodal triple hop distance and shuttle test time) and neuromuscular variables by means of isokinetic variables (peak torque, total work and fatigue index). Volunteers will perform pre-assessment, immediately post-race and post-intervention, and 24-hour post-intervention. The data will be expressed by mean and standard deviation, analyzed in the statistical package SPSS 20.0. A significance level of 5% and a 95% confidence interval will be considered for all measures.

Interventions

OTHERCold water immersion

OTHERWater immersion

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

MALE

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Body Mass Index between 18.5 and 30 kg/m2; * Street runners for at least 6 months; * Week frequency of at least 3 times; * Do not present cardiopathies, muscles and neurological diseases;

Exclusion criteria

* Hypersensitivity or allergies to cryotherapy; * Unable to complete the 10 km event on the day of the evaluation; * Do not complete or perform any of the study procedures for any reason (phobias, do not withstand the exposure time).

Design outcomes

Primary

Measure	Time frame	Description
Subjective perception of pain.	Up to 10 weeks	The subjective perception of pain will be measured by means of the visual analogic scale based on the self-report of the level of pain.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026